COVID antiviral order doubled ahead of PBS listing Paxlovid will be available on the Pharmaceutical Benefits Scheme from May, with ‘really positive responses’ reported so far.
TGA releases vaccine-related myocarditis severity details Fewer than 1% of all likely myocarditis or pericarditis cases linked to mRNA vaccines in Australia have been treated in intensive care.
Extra booster dose recommended by ATAGI The rollout of additional COVID-19 vaccine doses for those ‘at greatest risk of severe illness’ will commence ahead of winter to tie in with flu vaccination.
First safety data on Novavax released Early information on the administration of the Novavax vaccine in Australia is in line with clinical trials data, the TGA has reported.
ATAGI releases Moderna guidance for children aged 6–11 The RACGP has welcomed the announcement, but says more funding and support is needed for general practice.
Concerns for under-vaccinated pregnant population Pregnant women remain cautious when it comes to the COVID-19 vaccine, but growing safety evidence should boost uptake.
More than 40 children given incorrect dose of COVID-19 vaccine No serious adverse effects were reported among the tiny proportion of children aged 5–11 who received an adult dose.
Do current COVID-19 vaccines and treatments neutralise Omicron? New research has looked into a number of medications currently approved for use in Australia, as well as the role of a booster shot against the highly-infectious variant.
ATAGI releases clinical information for teen boosters Around 65% of teenagers aged 16 and over are now eligible to receive a COVID booster vaccine.
Does mixing COVID boosters provide better immunity? GP Dr Anna Samecki investigates whether it is better to mix or match the third COVID-19 booster dose.